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Gastric Electrical Stimulation for Gastroparesis 
Edy E Soffer
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Gastric electrical stimulation (GES) for gastroparesis has been in use for more than a decade. Multiple publications, consisting 
almost entirely of open label single center studies, reported a beneficial effect on symptoms, quality of life and nutritional 
status. Some predictors of better response to GES have been lately identified, primarily diabetic etiology and nausea and vom-
iting as the predominant symptoms. However, individual response to GES remains difficult to predict. The mechanism of action 
of GES remains poorly understood. Stimulation parameters approved in clinical practice do not regulate gastric slow wave ac-
tivity and have inconsistent effect on gastric emptying. Despite such limitations, gastric electrical stimulation remains a helpful 
intervention in some patients with severe gastroparesis who fail to respond to medical therapy.
(J Neurogastroenterol Motil 2012;18:131-137)
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Introduction
Electrical stimulation of the gut was introduced almost 5 dec-
ades ago in an attempt to treat postoperative ileus.
1 Later studies 
showed that gastric electrical stimulation (GES) with long dura-
tion pulses (in milliseconds) could pace the stomach,
1,2 enhance 
gastric emptying
3,4 and normalize gastric dysrhythmia.
2,5,6 Gastric 
electrical stimulation was consequently introduced in clinical 
practice worldwide as a treatment option for patients with recalci-
trant gastroparesis. Clinical experience with GES has been re-
ported by multiple studies, mostly from single centers. This ar-
ticle reviews technical aspects of GES, and the clinical data and 
status of this intervention for the treatment of gastroparesis. 
Technical Aspects of Gut Electrical 
Stimulation
A number of technical variables determine the effect of elec-
trical stimulation on gut tissue. Parameters of waveform applied 
by the pulse generator (shape, amplitude and frequency) and con-
sequently the energy delivered to the tissue are among the most 
important in determining tissue response. The electromechanical 
properties of the delivery system (the electrodes) are also impor-
tant. 
Two types of electrical stimulation have been used for gastro-
paresis. One type is referred to as a long-pulse duration and ap-
plies pulses with duration in milliseconds (usually few hundreds), 
at a frequency of a few cycles per minute. Hence, it is also com-
monly referred to as low-frequency stimulation, or high energy 
stimulation, since the amount of energy delivered to the tissue de-Edy E Soffer
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Figure 1. Gastric electrical stimulation in a patient with gastroparesis. 
The recording is obtained from an electrode positioned in the antrum 
(S4), while stimulation is delivered through an electrode positioned in 
the mid body of the stomach. Pacing stimuli, marked by dots, drive the 
electrical frequency as recorded in the antrum on a 1:1 ratio, indicating 
pacing (entrainment). In this experiment, stimulation with rectangular 
pulses of 30 ms, amplitude of 4 mA and frequency up to 10% higher than
the intrinsic gastric frequency was able to completely entrain the gastric
slow wave and normalize gastric dysrhythmia. This stimulus is referred 
to as long pulse duration/low frequency, and also as high energy 
(reproduced from Lin et al
2). 
Figure 2. An illustration of the type of electrical stimulation used by the 
Enterra system. Short bursts of short duration rectangular pulses (330 
μs each) are given at a frequency of 14 Hz in each burst. Bursts in turn 
last 0.1 seconds, and are delivered every 5 seconds. This type of stimulus
is referred to as short pulse duration/high frequency, and also as low 
energy.
pends, among others, on the product of pulse duration and its 
frequency. This waveform can entrain gastric slow waves (pace 
the stomach) and enhance gastric emptying (Fig. 1).
2 The high 
power consumption of this type of stimulation has limited its clin-
ical use. The second type of stimulus is referred to as a short- 
pulse duration, and applies pulses with duration in microseconds, 
at a hertz frequency (cycle/sec), hence also referred to as high-fre-
quency stimulation or low energy stimulation. Pulses can be de-
livered continuously, or in groups (trains). GES with trains of 
high frequency, short-duration pulses is currently the only type in 
clinical use for gastroparesis (Fig. 2). 
The structure of electrodes is also a factor in the choice of 
pulse parameters. It is important to ensure that the maximal elec-
trical charge applied at any time point on the electrodes will not 
exceed the maximum charging of the electrode-tissue capaci-
tance.
7,8 Exceeding this limit results in electrolysis, damage to the 
electrodes and formation of toxic electrochemical products in the 
tissue. Increased capacitance can be achieved by coating wires 
(such as platinum) with iridium oxide or changing pulse parame-
ters by reducing pulse amplitude or shortening pulse duration in 
order to reduce total charge. 
The Evolution of Gastric Electrical 
Stimulation
Interest in electrical stimulation was driven by the knowledge 
that the gastrointestinal (GI) tract throughout most of its length 
has natural pacemakers, and hence, application of electrical stim-
uli can modulate the myoelectric activity that they generate. 
Bilgutay et al
9 tested the use of electrical stimulation of the GI 
tract to treat ileus, and found that application of electrical stimuli 
to the stomach, via the tip of a nasogastric tube, resulted in aug-
mentation of gastric contractions and increased gastric emptying, 
as assessed by fluoroscopy. This initial impression was not con-
firmed by subsequent randomized controlled studies, that failed 
to show a significant effect of electrical stimulation on the dura-
tion of postoperative ileus.
10,11 Subsequent research shed light on 
gastrointestinal myoelectric activity and its relation to contractile 
activity,
1,12-15 and showed that electrical stimulation of the stom-
ach could control (entrain) gastric electrical activity. Further ob-
servations showed that optimal pacing could be achieved with 
stimulation at a frequency that was slightly higher than the natu-
ral intrinsic gastric slow wave frequency of humans or canines, 
and with pulse duration in the range of milliseconds (Fig. 2), and 
could also improve gastric emptying in health and disease.
2-4,15,16 
Later studies, using short duration pulses (in microseconds) and 
at higher frequencies found that such parameters could improve 
symptoms of nausea and vomiting.
17,18 The low power con-
sumption of this type of pulses allowed for implantation of pulse 
generators that were small enough to contain current battery de-
sign, and made the technology available for clinical use. Based on 
the clinical studies that followed, the Food and Drug Admini-
stration (FDA) granted the implantation system (Enterra
TM) a Gastric Electrical Stimulation for Gastroparesis
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Humanitarian Use Device status, as a treatment for uncommon 
conditions for which no effective therapy is available. The 
Enterra system (Medtronic, Minneapolis, MN, USA) is the on-
ly system approved for clinical use. Currently, per FDA criteria, 
GES is approved for patients with idiopathic or diabetic gastro-
paresis, with severe symptoms that have not responded to max-
imal medical therapy. However, by the authors’ experience, pa-
tients are frequently referred for consideration of GES after treat-
ment with a single pharmacological agent, and little attention to 
dietary modifications. Every effort should be made to educate pa-
tients about proper gatsroparetic diet, and to maximize pharma-
cologic therapy by providing medication in adequate strength, 
mode of delivery (liquid, orally disintegrated form or by rectal 
route) and in combination. Adequate glucose control is imper-
ative in diabetic patients. Only after all such measures fail to con-
trol symptoms, should GES be considered. 
Equipment and Implantation Procedure
The Enterra gastric stimulation system consists of 3 main el-
ements: a pair of leads, a pulse generator and a programming 
system. Two leads are surgically placed in the gastric wall, on the 
greater curvature, 10 cm proximal to the pylorus. The leads are 
connected to a pulse generator, placed in a subcutaneous pocket 
in the abdominal wall, in the left or right upper quadrants. The 
pulse generator was adapted from existing devices in clinical use, 
that could sustain long-term requirements of a low energy type of 
stimulation. The permanent implantable pulse generator is con-
trolled by an external programmer, which allows for interrogation 
and programming of stimulation parameters via a radio-telemetry 
link. The pulse generator is programmed to specific parameters, 
as shown in Figure 2. These parameters have been derived from 
earlier canine and human studies.
17,18
The Enterra system is implanted surgically, by laparotomy or 
increasingly by laparoscopy. Hospital stay following laparoscopic 
insertion is short, approximately 2 days
19 and is shorter when 
compared to placement via laparotomy.
20 The battery life extends 
to 5-10 years, depending on the pulse parameters used.
21 When 
the battery is depleted, the pulse generator is replaced by local 
intervention. 
Clinical Experience With Gastric Electrical 
Stimulation
Published data on GES for gastroparesis are derived almost 
entirely from open label studies, mostly performed in a selective 
number of centers with large experience in this therapy.
19,22-30 
Published studies consistently demonstrate that GES has a bene-
ficial effect in patients with gastroparesis. The few studies that 
had a double blind phase reported comparable outcome,
23,30 but 
their results were questioned because of study design issues. 
Besides the improvement in symptoms, GES was found to im-
prove nutritional status
22,31 and quality of life.
23,32 GES was also 
found to reduce utilization of health care facilities and con-
sequently to reduce health care costs associated with gastro-
paresis.
33,34 Table provides a more detailed information from 
leading studies. Lately, the use of GES was expanded to etiol-
ogies beyond diabetic and idiopathic gastroparesis. GES was 
tried in post-surgical gastroparesis,
35-37 intestinal pseudo-ob-
struction
38 and post organ transplant,
39 with encouraging results. 
Data, however,  are too few, and more studies are needed to de-
termine the efficacy of GES in these groups of patients.
Different concepts of stimulation are also being investigated 
in order to maximize efficacy. A variation on the single channel 
gastric stimulation is achieved by the use of a number of electro-
des, positioned at intervals along the long axis of the stomach with 
application of sequential stimulation intended to entrain gastric 
slow waves and to induce a propagated electrical and contractile 
sequence. Multichannel pacing requires a fraction of the energy 
used in single channel pacing,
40 and it improves gastric emptying 
and symptoms in experimental models of gastroparesis
41 and in 
diabetic patients with gastroparesis.
42 A different approach was 
used in an animal model delivered with high frequency stim-
ulation (microprocessor-controlled, phase-locked bipolar trains 
of pulses at a frequency of 50 Hz, 8-14 V), applied to electrodes 
that were placed circumferentially along the distal stomach. 
Sequential stimulation resulted in sequential contractions that en-
hanced gastric emptying.
43 Unlike the approved high frequency 
system (Enterra
TM), which is implanted in thousands of patients 
and with long-term results from multiple studies, these recent 
concepts of stimulation have been studied in a handful of sub-
jects, or solely in the animal models. Therefore their technical fea-
sibility and clinical efficacy remain to be explored in clinical trials. 
Long-term studies report a complication rate of 7%-10%, the 
main one being the infection on subcutaneous pocket.
22,44,45 Less 
common complications include erosion of the abdominal wall by 
the device, penetration of the leads through the gastric wall, or 
tangling of wires in the generator pocket and formation of 
adhesions. These complications are generally managed surgically. 
In case of the infection on pocket, the pulse generator needs to be 
removed; however, it can be reinserted once the infection is fully Edy E Soffer
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Table. Studies of Gastric Electrical Stimulation for the Treatment of Gastroparesis
References Study Follow-up Patients (n) Results/Outcomes
Abell et al,
23 2003 Multicenter, prospective, double- 
blind placebo-controlled phase of 
1 month, followed by open label 
phase.
Aim: Evaluate the long term effect 
of GES on GI Symptoms.
1 yr 33 (17 DG, 16 IG) Significant improvement in vomiting 
frequency and TSS in the first phase. 
Significant improvement in vomiting, 
TSS and QOL during open label 
phase. 
Anand et al,
44 2007  Open label study from 3 regional 
centers. 
Evaluation of long-term effects of 
GES on symptoms, QOL and 
survival.
Median of 4 yr 214 (156 with permanent 
implantation)
45 DG, 146 IG, 23 
Post-surgical
Significant improvement in vomiting 
frequency, TSS and QOL.  
Abell et al,
25 2002  Open label, prospective, multicenter 
study, with temporary GES in the 
first phase. Evaluation of 
permanent GES in patients who 
responded to temporary GES. 
1 yr 38 (9 DG, 24 IG, 5 
Post-surgical)
Marked reduction (> 80%) in nausea 
and vomiting in 33 patients. 
Alternative nutrition discontinued in 
9/14. 
Cutts et al,
24 2005 Evaluation of long-term effects of 
GES vs medical therapy on 
symptoms, QOL and costs.
3 yr 18 (2 DG,  16 IG). 
9 had GES, control 
group of 9 patients on 
medical therapy.
Better control of symptoms and lower 
health care costs in the GES group.
Gourcerol et al,
26 2007 Evaluation of GES in patients with 
delayed vs. normal gastric 
emptying. 
6 mo 15 (7 with normal 
emptying, 8 with 
delayed)
Comparable improvement in symptoms 
and QOL in both groups. 
Islam et al,
27 2008 Evaluation of GES in pediatric 
population.
8-42 mo 9 (average age, 14 yr) Improvement in symptoms and  QOL. 
Maranki et al,
34 2008  Describe predictive factors for 
outcome of GES.
5 mo 28 (16 IG, 12 DG) Improvement in nausea and vomiting, 
but not in bloating or abdominal pain. 
Use of opiates associated with poor 
response. Better response in diabetic 




Evaluation of GES in post-surgical 
patients.
1 yr 16 Improvement in symptoms and QOL 
and reduced hospitalizations and 
health care costs.  Alternative nutrition 
discontinued in 4 patients. 
Salameh et al,
37 2007 Evaluation of GES in patients with 
post Roux-en-Y gastric bypass.
6 mo   5 Improvement in symptoms and TSS. 
Lin et al,
31 2006  Evaluation of long-term outcome of 
GES.
≥ 3 yr 55 (39 DG, 9 IG, 7 
post-surgical) 
Improvement in TSS, sustained. 
Reduced hospitalizations, use of 
medications and need for alternative 
nutrition. Diabetic patients showed a 
significant reduction in HbA1C from 
9.5% to 7.9%.
Mason et al,
28 2005 Evaluation of the effect of GES on 
symptoms of gastroparesis.
20 mo 29 (24 DG, 5 IG) Significant increase in BMI, 70% 
reported good to excellent outcome, 
reduced need for alternative nutrition.
Brody et al,
19 2008 Evaluation of the effect of GES on 
symptoms of gastroparesis.
12 mo 50 (20 DG, 25 IG, 2 post 
surgical, 3 connective 
tissue disorder)
Significant improvement in nausea, 
vomiting and TSS. 
McKenna et al,




19 (10 DG, 6 IG, 3 post 
surgical)
Improvement in symptoms and TSS, 
but not in QOL.
GES, gastric electrical stimulation; GI, gastrointestinal; DG, diabetic gastroparesis; IG, idiopathic gastroparesis; TSS, total symptom score; QOL, quality of life; HbA1C,
hemoglobin A1C; BMI, body mass index.Gastric Electrical Stimulation for Gastroparesis
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controlled.
44
Given the invasive nature of this intervention, efforts were 
made to identify factors that can predict good response to 
therapy. A few clinical features were found to be associated with 
less than optimal response, such as the use of opiates,
46 and idio-
pathic, rather than diabetic etiology.
23,34 Pain and bloating were 
not improved compared with nausea and vomiting.
46 Thus, dia-
betic patients with gastroparesis, with nausea and vomiting as 
their predominant symptoms, appeared to be the best candidates 
for GES. Unfortunately, individual response to GES remains 
unpredictable. The need to predict response generated an interest 
in the use of temporary gastric electrical stimulation, using trans-na-
sal mucosal electrodes, assessing the response to a few days of 
therapy as a predictor of response to long term therapy with the 
Enterra system,
47 but there are no data available so far from dou-
ble blind, control studies to support its use for such purpose. 
Also, once implantation is performed, there is no clear strategy 
for addressing patients who do not respond to GES. Various ma-
nipulations of pulse parameters have been suggested
48 but data 
are not yet sufficient to support such approach. 
Mechanisms of Gastric Electrical 
Stimulation
In general, electrical stimulation of gut tissue can modulate 
the neuromuscular function of the organs involved and/or affect 
afferent neural activity emanating from the organs. This concept 
has been tested in both animal models and humans, however, the 
mechanisms of action of GES in gastroparesis remain poorly 
understood. Studies in animals
1 and later in humans
2 have clearly 
shown that entrainment (pacing) of gastric slow waves could be 
achieved with GES using low-frequency/long-duration pulse pa-
rameters, and that these parameters could enhance gastric empty-
ing.
3,4 Initial reports from animal and human studies suggested 
that similar effects can be achieved with GES when using 
short-duration pulses.
17,18 However, subsequent studies, using 
the pulse parameters of the implantable Enterra system, did not 
support these initial observations. Enterra parameters did not 
control vasopressin-induced gastric dysrhythmia in an animal 
model, though it improved vomiting,
49 while in humans, GES 
did not affect gastric electrical activity in patients with gastro-
paresis, as measured by electrogastrography.
50 The effect of GES 
on gastric emptying is inconsistent, with some studies showing 
enhancement of gastric emptying,
19,25 o b s e r v e d  o n l y  i n  d i a -
betics,
23 or no improvement.
45,51 Given the variable correlation 
between gastric emptying and symptoms of gastroparesis,
52 and 
keeping in mind the possibility of spontaneous resolution of idio-
pathic gastroparesis over time,
53 the system should not be used to 
achieve a prokinetic effect, such as to treat patients who suffer 
from gastric bezoars or severe gastroesophageal reflux disease. 
A more plausible mechanism is perhaps the effect of GES on 
gastric biomechanical activity. Both, low-frequency/long-dura-
tion and high-frequency/short-duration pulses were shown to re-
duce gastric tone in animal models
54,55 and reduced symptoms in-
duced by gastric distension.
55 Impairment of gastric accom-
modation has been documented in patients with functional dys-
pepsia and diabetic gastropathy,
56,57 and such impairment in turn 
was associated with gastrointestinal symptoms, primarily early 
satiety and weight loss,
56 suggesting a possible mechanism for 
GES in symptom relief. The afferent modulation and central  
mechanism of GES remain unclear. In dogs, the antiemetic effect 
is vagally mediated, since it is abolished by vagal disruption,
49 but 
GES was also shown to improve symptoms in post surgical gas-
troparesis, some with vagal disruption.
35-37 GES was found to in-
crease activity in the thalamus of patients with gastroparesis, as 
detected by positron emission tomography.
58 These data are diffi-
cult to interpret, particularly since perturbation of the gut is likely 
to have a central representation, and hence its mere presence may 
not necessarily indicate a neural mechanism. 
Areas of Uncertainty
In spite of the encouraging data provided by the studies pub-
lished so far, there remains an element of skepticism with regard 
to this intervention,
59 driven by the lack of a convincing double 
blind, placebo (sham-stimulation) controlled study, sufficiently 
powered to provide conclusive data regarding the efficacy. However, 
clinical experience, and most importantly, the lack of the effective 
therapy for gastroparesis, support the use of GES in refractory 
patients with debilitating symptoms who exhausted all available 
medical regimens. The lack of reliable measures to predict re-
sponse to therapy in individual patients, particularly given the in-
vasive nature of this intervention, continues to limit the applica-
tion of this intervention. 
Conclusion
Considerable clinical evidences support the use of GES for 
the treatment of drug refractory gastroparesis. The Enterra sys-
tem is the only one approved for such purpose. Improvement of Edy E Soffer
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pulse parameters, the potential use of temporary stimulation and 
the incorporation of variables that can predict better response to 
stimulation may improve the efficacy of the current system. New 
systems under investigation may prove to be more efficacious and 
provide better control of symptoms coupled with prokinetic effect. 
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